Aligos Therapeutics (ALGS) Change in Account Payables (2021 - 2025)
Historic Change in Account Payables for Aligos Therapeutics (ALGS) over the last 5 years, with Q3 2025 value amounting to $752000.0.
- Aligos Therapeutics' Change in Account Payables rose 11843.59% to $752000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 105550.0%. This contributed to the annual value of $54000.0 for FY2024, which is 10243.35% up from last year.
- As of Q3 2025, Aligos Therapeutics' Change in Account Payables stood at $752000.0, which was up 11843.59% from -$402000.0 recorded in Q2 2025.
- Over the past 5 years, Aligos Therapeutics' Change in Account Payables peaked at $4.0 million during Q2 2024, and registered a low of -$4.1 million during Q3 2024.
- In the last 5 years, Aligos Therapeutics' Change in Account Payables had a median value of $169000.0 in 2022 and averaged $69684.2.
- The largest annual percentage gain for Aligos Therapeutics' Change in Account Payables in the last 5 years was 84916.47% (2024), contrasted with its biggest fall of 125966.67% (2024).
- Quarter analysis of 5 years shows Aligos Therapeutics' Change in Account Payables stood at $399000.0 in 2021, then surged by 352.63% to $1.8 million in 2022, then plummeted by 123.42% to -$423000.0 in 2023, then surged by 60.05% to -$169000.0 in 2024, then soared by 544.97% to $752000.0 in 2025.
- Its Change in Account Payables was $752000.0 in Q3 2025, compared to -$402000.0 in Q2 2025 and $1.7 million in Q1 2025.